Anavex Life Sciences Corp (AVXL)
3.445
+0.06
(+1.62%)
USD |
NASDAQ |
Apr 26, 14:43
Anavex Life Sciences Shares Outstanding: 82.11M for Feb. 7, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 07, 2024 | 82.11M |
December 31, 2023 | 82.09M |
November 24, 2023 | 82.09M |
September 30, 2023 | 82.07M |
August 08, 2023 | 81.95M |
June 30, 2023 | 81.39M |
May 08, 2023 | 80.84M |
March 31, 2023 | 80.24M |
March 27, 2023 | 79.61M |
February 07, 2023 | 78.03M |
February 03, 2023 | 78.03M |
January 27, 2023 | 78.03M |
December 31, 2022 | 78.03M |
November 28, 2022 | 77.96M |
September 30, 2022 | 77.94M |
August 09, 2022 | 77.94M |
June 30, 2022 | 77.94M |
May 10, 2022 | 77.41M |
March 31, 2022 | 77.16M |
March 28, 2022 | 76.92M |
February 08, 2022 | 76.17M |
December 31, 2021 | 76.16M |
November 19, 2021 | 76.02M |
September 30, 2021 | 75.92M |
August 12, 2021 | 75.71M |
Date | Value |
---|---|
June 30, 2021 | 75.71M |
June 24, 2021 | 72.42M |
May 11, 2021 | 70.04M |
March 31, 2021 | 70.03M |
March 29, 2021 | 70.03M |
February 12, 2021 | 69.49M |
December 31, 2020 | 66.96M |
December 28, 2020 | 66.96M |
September 30, 2020 | 62.05M |
August 04, 2020 | 60.19M |
June 30, 2020 | 60.08M |
May 07, 2020 | 58.66M |
April 27, 2020 | 58.66M |
March 31, 2020 | 58.66M |
February 19, 2020 | 58.66M |
February 11, 2020 | 58.66M |
February 06, 2020 | 58.66M |
December 31, 2019 | 57.08M |
December 12, 2019 | 56.12M |
September 30, 2019 | 52.65M |
September 11, 2019 | 52.65M |
August 07, 2019 | 52.65M |
July 02, 2019 | 51.66M |
June 30, 2019 | 51.51M |
June 07, 2019 | 50.73M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
49.12M
Minimum
May 08 2019
82.11M
Maximum
Feb 07 2024
69.37M
Average
75.71M
Median
Jun 30 2021
Shares Outstanding Benchmarks
Ventyx Biosciences Inc | 59.24M |
Checkpoint Therapeutics Inc | 35.69M |
Vertex Pharmaceuticals Inc | 258.31M |
Sarepta Therapeutics Inc | 93.86M |
NovaBay Pharmaceuticals Inc | 30.10M |